On January 3, the federal government opened the 118th Congress – a group that will undoubtedly have a significant influence over the future of the life sciences industry over the next several years.
Our Trendspotting Report will help your company:
- Stay up to date on the latest legislative and policy developments
- Understand what these developments might mean for the life sciences industry, including drug pricing and manufacturing approaches
- Be prepared to react, adapt, and thrive to whatever changes may come
Our Life Sciences attorneys and government relations professionals keep an ear to the ground of what's happening on Capitol Hill and the FDA and have close relationships with the players influencing federal laws. We've gathered our insights to help you position your company for success in 2023 and beyond.
Download your Life Sciences Trendspotting 2023 Report >
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.